CROATIAN MEDICAL JOURNAL, cilt.48, sa.2, ss.234-239, 2007 (SCI-Expanded)
Aim To evaluate the efficacy and safety of using recombinant human DNase (rhDNase) in diminishing persistent atelectasis unresponsive to conventional treatment and mucus plugging in newborns with insufficient ability to clear thick and purulent airway secretions.